Pharma & Biotech

First reported 15 hours ago - Updated 50 mins ago - 6 reports

BRIEF: Drug giant ends arthritis deal with Alder BioPharma

Sept. 02--Alder BioPharmaceuticals of Bothell said Bristol-Myers Squibb is ending an arthritis-drug collaboration pact under which Alder earned more than $100 million since 2009. The news sent Alder's shares down $2.24, or 13.1 percent, to close at $ ... [Published Crawford Financial Planning - 50 mins ago]
First reported 13 hours ago - Updated 3 hours ago - 21 reports

Human trial of experimental Ebola vaccine begins

An American missionary doctor working in Liberia has tested positive for the deadly Ebola virus.The director of the Center for Disease Control told CNN the Ebola outbreak is "spiraling out of control," just before briefing President Obama on the crisis ... [Published CNN - 3 hours ago]
First reported 16 hours ago - Updated 4 hours ago - 5 reports

Teva Announces Positive Results from Clinical Asthma Treatment Trials

Teva Pharmaceutical Industries Ltd. announced on Sept. 2 that reslizumab, an investigational anti-IL-5 monoclonal antibody, demonstrated clear levels of efficacy in achieving the primary endpoint of reduction in the frequency of clinical asthma exacerbations ... [Published - 4 hours ago]
First reported 23 hours ago - Updated 4 hours ago - 4 reports

Pfizer's Vaccine for C. Difficile Receives FDA Fast Track Designation

Pfizer Inc. announced on Aug. 28 that FDA has granted Fast Track designation to the company’s investigational Clostridium difficile ( C. difficile ) vaccine candidate. Currently in Phase II clinical development, the vaccine candidate is designed to prevent ... [Published - 4 hours ago]
First reported 12 hours ago - Updated 4 hours ago - 7 reports

Novartis may have game-changing drug

Share this article: Novartis is poised to change the way heart-failure patients are treated, if weekend reaction to data surrounding its experimental drug LCZ696 is any indication. The company released data at the European Society of Cardiology Congress ... [Published Medical Marketing And Media - 4 hours ago]
First reported Sep 01 2014 - Updated 6 hours ago - 18 reports

Cabozantinib (Cometriq) Fails to Meet Primary Endpoint in Pivotal Study of Men With Metastatic Prostate Cancer

Drug currently approved for thyroid cancerDisappointing results have been reported from the final analysis of a pivotal phase III trial of cabozantinib (Cometriq, Exelixis, Inc.) in men with metastatic castration-resistant prostate cancer (mCRPC) whose ... [Published PT Community - 7 hours ago]
First reported 15 hours ago - Updated 9 hours ago - 3 reports

EMD Group (EMD Millipore Headquarters) And Massachusetts General Hospital Collaborate To Better Understand Systemic Lupus Erythematosus And Lupus Nephritis

BILLERICA, Mass.--(BUSINESS WIRE)--EMD Serono Research and Development Institute, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, entered into a collaborative research agreement with Massachusetts General Hospital (MGH) to further the understanding ... [Published BioSpace - 9 hours ago]
First reported 21 hours ago - Updated 9 hours ago - 5 reports

Novo Nordisk Exits Inflammatory Disorders, at Risk of Jobs

Novo Nordisk said today it will end all R&D activities for inflammatory disorders treatments and focus more on its diabetes prevention and treatment, obesity and diabetes complications—a decision it projected will cost up to about 200 jobs.A total 400 ... [Published Genetic Engineering News - 9 hours ago]
First reported 16 hours ago - Updated 10 hours ago - 4 reports

Tokai Pharmaceuticals Appoints As Chief Financial Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing novel therapies for prostate cancer and other hormonally-driven diseases, today announced the appointment of Lee Kalowski as chief financial ... [Published BioSpace - 10 hours ago]
First reported Sep 01 2014 - Updated 13 hours ago - 11 reports

New Ebola vaccine trial begins

MONROVIA, LIBERIA (CNN) – The first human safety trial for an experimental Ebola vaccine begins this week.This comes as the number of cases of the deadly virus increases.The Food and Drug Administration gave the green light for researchers at the U.S. ... [Published Live 5 WCSC - 13 hours ago]
First reported Sep 01 2014 - Updated 16 hours ago - 8 reports

Novo Nordisk ends inflammatory R&D, sticks to diabetes

Novo Nordisk is pulling out of inflammatory disorder R&D to increase its diabetes and obesity efforts, following the failure of an investigational rheumatoid arthritis drug.The decision to discontinue comes after the Danish firm ended Phase II development ... [Published Pharma Times - 16 hours ago]
First reported Sep 01 2014 - Updated Sep 02 2014 - 17 reports

Drug Gives 'New Hope' Against Heart Failure, Expert Says

By Steven ReinbergSATURDAY, Aug. 30, 2014 (HealthDay News) -- In a head-to-head comparison, an experimental drug was more effective than standard treatment at preventing deaths and hospitalizations in heart failure patients.According to the study authors, ... [Published Bio-Medicine - Sep 01 2014]


"With the encouraging results on such an objective and meaningful endpoint, we plan to engage with health authorities, patient foundations, and the clinical/research community in the next several months to define the next steps that may ultimately lead to new options for children with Rett syndrome and other mitochondrial diseases" said Matthew Klein RettRett syndrome affects one in every 10,000 to 15,000 live female births...
...of understanding ADC drug development and working within a biological matrix," said Chris Radloff, vice president, LC/ MS Business at AB SCIEX. "Utilising these molecules is difficult and by forming this partnership, ADC developers can now reduce complications, and obtain accurate results that will ultimately lead to safer, more effective therapies."
"We believe that Luye, with its strong R&D capability in oncology, will develop Poziotinib as a differentiated targeted therapy to its full potential in China market. Hanmi will also try its best to contribute to the treatment of cancer together with Luye by developing Poziotinib with a well-planned global strategy" , said Mr. Sung Ki Lim, Chairman of Hanmi
...Family members and friends gathered at Campbell's Grandmother's house to remember the father of two. "We were able to tell each other man to man that I love you and he told me that he loved me also" said Lawrence Campbell, Earl's father. "That's wha

More Content

All (31703) | News (31330) | Reports (1) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (81)
sort by: Date | Relevance
Bioscience board OKs accelerator plan [Published Temple Daily Telegram - 34 mins ago]
Edison Pharmaceuticals Announces Phase 2 Positi... [Published Pettinga Financial Advisors - 36 mins ago]
Edison Pharmaceuticals Announces Phase 2 Positi... [Published CEOWorld Magazine - 36 mins ago]
Antisense Therapeutics Limited announces ATL110... [Published Reuters - 39 mins ago]
BRIEF: Drug giant ends arthritis deal with Alde... [Published Crawford Financial Planning - 50 mins ago]
AB SCIEX, Dalton Pharma to Advance Antibody-Dru... [Published PharmaAsia - 50 mins ago]
Luye and Hanmi Enter into Partnership to Develo... [Published Noodls - 55 mins ago]
Luye Pharma Acquired 57.98% Stake of Beijing Ji... [Published Noodls - 55 mins ago]
Aus Pharma lifts profit guidance [Published Finance News Network - 1 hour ago]
Regional Urogenomic Liaison (RUL) - Virginia [Published PharmaDiversity - 1 hour ago]
Sr. Compensation Analyst [Published PharmaDiversity - 1 hour ago]
Associate Developer [Published PharmaDiversity - 1 hour ago]
2 Your Health: Drug offers new hope for chronic... [Published WCBD - 1 hour ago]
Principal Scientist (R5) - Study Director [Published PharmaDiversity - 1 hour ago]
Johnson & Johnson looks to sell medical device ... [Published Medical Plastics News - 1 hour ago]
ICMR issues draft guidelines for diagnosis & ma... [Published PharmaBiz - 1 hour ago]
ConvaTec to invest Rs.150 cr. to expand its rea... [Published PharmaBiz - 1 hour ago]
MSPC launches software to detect drug to drug i... [Published PharmaBiz - 1 hour ago]
ISM units in Tamil Nadu face closure due to sus... [Published PharmaBiz - 1 hour ago]
HSI wants other Asian countries to emulate DCGI... [Published PharmaBiz - 1 hour ago]
Engineers develop new sensor to detect tiny ind... [Published Cosmetics Design North America - 2 hours ago]
Mary Kay appoints new VP Corp. Comms and CSR [Published Cosmetics Design North America - 2 hours ago]
Sun care manufacturers tapping into 'easy use' ... [Published Cosmetics Design North America - 2 hours ago]
Pleas for NHS to buy costly but effective cance... [Published - 2 hours ago]
Medical Sales Representative - GP/Hospital - Kent [Published Pharma Field - 2 hours ago]
Diabetes Account Managers [Published Pharma Field - 2 hours ago]
Key Account Manager - Transplantation - Yorkshi... [Published Pharma Field - 2 hours ago]
Territory Sales Manager - Orthopaedics - North ... [Published Pharma Field - 2 hours ago]
Key Account Manager - GI - West Yorks & South Y... [Published Pharma Field - 2 hours ago]
A Randomized Pilot Trial of Remote Ischemic Pre... [Published - 2 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
Content Volume
Document Volume


sort by: Date | Relevance
From Sprint And TechStars To The FDA, A Look At... [Published TechCrunch - Oct 10 2013]
The health-care industry in the U.S. is broken, and considering the industry itself represents some 18 percent of the U.S. economy, it’s a sizable problem. While other sectors have begun to adapt, health care has managed to resist change — particularly ...

Press Releases

sort by: Date | Relevance
Using genomics to make personalized, safer medi... [Published PR Newswire - Feb 03 2014]
Endo Completes Acquisition of Specialty Generic... [Published PR Newswire - Feb 03 2014]
10 Reasons Why Biometric Exit May Advance in 2014 [Published PR Newswire - Feb 03 2014]
Regado Biosciences Announces $20 Million Privat... [Published PR Newswire - Jan 31 2014]
Novo Nordisk Promotes Eddie Williams to Senior ... [Published PR Newswire - Jan 30 2014]
1 2 3 4 5 6 7 8 9 10 ...
Contact Us

Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.